These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20106478)

  • 1. Lipoprotein(a) and ischemic heart disease--a causal association? A review.
    Kamstrup PR
    Atherosclerosis; 2010 Jul; 211(1):15-23. PubMed ID: 20106478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment.
    Varbo A; Benn M; Nordestgaard BG
    Pharmacol Ther; 2014 Mar; 141(3):358-67. PubMed ID: 24287311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentanucleotide repeat polymorphism, lipoprotein(a) levels, and risk of ischemic heart disease.
    Kamstrup PR; Tybjaerg-Hansen A; Steffensen R; Nordestgaard BG
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3769-76. PubMed ID: 18682504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) and risk of myocardial infarction--genetic epidemiologic evidence of causality.
    Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
    Scand J Clin Lab Invest; 2011 Apr; 71(2):87-93. PubMed ID: 21231777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remnant cholesterol and ischemic heart disease.
    Varbo A; Nordestgaard BG
    Curr Opin Lipidol; 2014 Aug; 25(4):266-73. PubMed ID: 24977981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.
    Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG
    Circulation; 2013 Sep; 128(12):1298-309. PubMed ID: 23926208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.
    Boffa MB; Marcovina SM; Koschinsky ML
    Clin Biochem; 2004 May; 37(5):333-43. PubMed ID: 15087247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.
    Lamarche B; St-Pierre AC; Ruel IL; Cantin B; Dagenais GR; Després JP
    Can J Cardiol; 2001 Aug; 17(8):859-65. PubMed ID: 11521128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a): resurrected by genetics.
    Kronenberg F; Utermann G
    J Intern Med; 2013 Jan; 273(1):6-30. PubMed ID: 22998429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a): a causal independent risk factor for coronary heart disease?
    Gudnason V
    Curr Opin Cardiol; 2009 Sep; 24(5):490-5. PubMed ID: 19623058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic evidence that lipoprotein(a) associates with atherosclerotic stenosis rather than venous thrombosis.
    Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2012 Jul; 32(7):1732-41. PubMed ID: 22516069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men.
    Clarke R; Emberson JR; Parish S; Palmer A; Shipley M; Linksted P; Sherliker P; Clark S; Armitage J; Fletcher A; Collins R
    Arch Intern Med; 2007 Jul; 167(13):1373-8. PubMed ID: 17620530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases.
    Kronenberg F
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):87-100. PubMed ID: 26896185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) as a marker for coronary heart disease.
    Duriez P; Dallongeville J; Fruchart JC
    Br J Clin Pract Suppl; 1996 Jan; 77A():54-61. PubMed ID: 8729591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) as a marker for coronary heart disease.
    Duriez P; Dallongeville J; Fruchart JC
    Br J Clin Pract Suppl; 1994 Dec; (77):51-8. PubMed ID: 19496273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a): more interesting than ever after 50 years.
    Dubé JB; Boffa MB; Hegele RA; Koschinsky ML
    Curr Opin Lipidol; 2012 Apr; 23(2):133-40. PubMed ID: 22327610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between common lipoprotein lipase gene sequence variants, hyperinsulinemia, and risk of ischemic heart disease: A population-based study.
    Jeppesen J; Hansen TW; Torp-Pedersen C; Madsbad S; Ibsen H; Jørgensen T; Fenger M
    Atherosclerosis; 2010 Aug; 211(2):506-11. PubMed ID: 20347446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.
    Varbo A; Benn M; Tybjærg-Hansen A; Grande P; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):451-7. PubMed ID: 21071687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilirubin and risk of ischemic heart disease in Korea: a two-sample Mendelian randomization study.
    Jeon C; Lee JY; Lee SJ; Jung KJ; Kimm H; Jee SH
    Epidemiol Health; 2019; 41():e2019034. PubMed ID: 31319653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis.
    Stender S; Frikke-Schmidt R; Nordestgaard BG; Grande P; Tybjaerg-Hansen A
    J Intern Med; 2013 Jan; 273(1):59-68. PubMed ID: 22805420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.